The Patient-Centered Outcomes Research Institute, an independent board tasked with comparing the effectiveness of medical treatments, will announce its priorities for spending $3 billion over the next decade. Some patient advocacy groups worry that the board's recommendations, which are not intended to be binding, will cause insurers to drop coverage for certain treatments.

Full Story:
Kaiser Health News

Related Summaries